![]() Bristol Myers Squibb Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products. | ![]() AstraZeneca AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines. | ||
Founding Date | Founding Date 1863 | Founding Date 1887 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Princeton, US HQ Mulgrave, AU Pinewood, AU Wien, AT Braine L'alleud, BE Bruxelles, BE São Paulo, BR see more | Locations Cambridge, GB HQ Alger, DZ Buenos Aires, AR Macquarie Park, AU Macquarie Park, AU North Ryde, AU Wien, AT see more | |
Employees | Employees 87,7571% decrease | Employees 34,100 | Employees 94,300 |
Valuation ($) | Valuation ($) 27.1 b | Valuation ($) 97.8 b | Valuation ($) 2.7 b |
Financial | |||
Revenue (est.) | Revenue (est.) €45.6b (FY, 2025) | Revenue (est.) $48.2b (FY, 2025) | Revenue (est.) $58.7b (FY, 2025) |
Cost of goods | Cost of goods €14b (FY, 2025) | Cost of goods $13.9b (FY, 2025) | Cost of goods $4.9b (FY, 2025) |
Gross profit | Gross profit €32.5b (FY, 2025) | Gross profit $34.3b (FY, 2025) | Gross profit $54.2b (FY, 2025) |
Net income | Net income (€3.6b) (FY, 2025) | Net income $7.1b (FY, 2025) | Net income $10.2b (FY, 2025) |
Operating ⚠ | |||
Countries | Countries 83 (FY, 2021) | Countries N/A | Countries 130 (FY, 2021) |
Funding | |||
Total funding raised | Total funding raised $ 3.5b | Total funding raised $ 15.5m | Total funding raised $ 1b |

Bristol-Myers Squibb (BMS) is a company engaged in the discovery, development, licensing, manufacturing, marketing, and distribution of biopharmaceutical products.
View company
AstraZeneca is a biopharmaceutical company specializing in the discovery, development, manufacturing, and marketing of prescription medicines.
View company